FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2012060901> ?p ?o ?g. }

• W2012060901 endingPage "221" @default.
• W2012060901 startingPage "213" @default.
• W2012060901 abstract "Abstract Activin and inhibin are structurally related dimeric glycoproteins belonging to the transforming growth factor-β superfamily of proteins which are synthesized and secreted by the granulosa cells of the ovary. Although initially characterized by their ability to influence FSH secretion from pituitary cells, paracrine regulatory roles of these factors on neighboring ovarian theca interna have been suggested. While inhibin has been shown to increase and activin to decrease the production of androgens, the mechanisms of action are not well defined, partly due to difficulties in obtaining adequate numbers of thecal cells from individual patients or animal models. Using a unique human ovarian thecal-like tumor (HOTT) cell culture model system we investigated the biochemical and molecular mechanisms controlling C19 steroidogenesis and the effects of activin and inhibin on the activity and expression of key ovarian thecal steroidogenic enzymes, cholesterol side-chain cleavage cytochrome P450 (P450scc), 3β-hydroxysteroid dehydrogenase (3βHSD) and 17α-hydroxylase/17,20 lyase cytochrome P450 (P450c17). Steroid production, level of steroidogenic enzyme mRNA expression, and enzyme activity following treatment with forskolin, inhibin-A and activin-A were examined. Basal steroid production, enzyme activities, and steroidogenic enzyme mRNA levels were not markedly different following treatment with activin (25 ng/ml) or inhibin (25 ng/ml) alone. Forskolin (10 μ m ) markedly increased production of both androstenedione (fivefold) and progesterone (threefold) as well as the activity of 3βHSD (sevenfold), and P450c17 (sevenfold) over basal. Forskolin stimulated the expression of mRNA for P450scc (fourfold), 3βHSD (threefold), and P450c17 (eightfold) over basal. Androstenedione accumulation was decreased by 60% in the forskolin plus activin group compared with forskolin alone, while progesterone production was maintained. This was attributed to a reduction of P450c17 mRNA (45% of forskolin alone) and activity (45% of forskolin alone). In contrast, co-treatment with forskolin and inhibin increased androstenedione production by 40% while decreasing progesterone by 40% compared with forskolin alone. Concomitantly, this was associated with a higher P450c17 mRNA expression (1·5-fold) and activity (two-fold) but with minimal effects on the mRNA for 3βHSD and P450scc. HOTT cell responses to activin (0·05–50 ng/ml) and inhibin (0·05–50 ng/ml) in the presence of forskolin demonstrated dose-dependent effects on the steroid accumulation, enzymatic activity and mRNA expression of P450c17. Additionally, the differences seen on mRNA expression of steroidogenic enzymes in response to these factors were time-dependent. In summary, forskolin stimulated C19 steroid production from HOTT cells by increasing the expression of all steroidogenic enzymes examined. Inhibin and activin exerted differential effects on the expression of these enzymes which resulted in alterations in the steroid profile toward production of C19 steroids in the case of inhibin and away from C19 steroids in the case of activin. The influence of these important intraovarian factors on the expression of P450c17, a pivotal enzyme in thecal cell production of C19 steroids, could impact greatly on the follicular milieu of a normal developing follicle as well as in pathophysiological disorders such as polycystic ovarian syndrome. Journal of Endocrinology (1996) 148, 213–221" @default.
• W2012060901 created "2016-06-24" @default.
• W2012060901 creator A5065195566 @default.
• W2012060901 creator A5066225680 @default.
• W2012060901 creator A5071052252 @default.
• W2012060901 creator A5073033743 @default.
• W2012060901 creator A5085226848 @default.
• W2012060901 creator A5088078573 @default.
• W2012060901 date "1996-02-01" @default.
• W2012060901 modified "2023-09-27" @default.
• W2012060901 title "Inhibin and activin differentially regulate androgen production and 17α-hydroxylase expression in human ovarian thecal-like tumor cells" @default.
• W2012060901 doi "https://doi.org/10.1677/joe.0.1480213" @default.
• W2012060901 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8699135" @default.
• W2012060901 hasPublicationYear "1996" @default.
• W2012060901 type Work @default.
• W2012060901 sameAs 2012060901 @default.
• W2012060901 citedByCount "34" @default.
• W2012060901 countsByYear W20120609012013 @default.
• W2012060901 countsByYear W20120609012015 @default.
• W2012060901 countsByYear W20120609012018 @default.
• W2012060901 crossrefType "journal-article" @default.
• W2012060901 hasAuthorship W2012060901A5065195566 @default.
• W2012060901 hasAuthorship W2012060901A5066225680 @default.
• W2012060901 hasAuthorship W2012060901A5071052252 @default.
• W2012060901 hasAuthorship W2012060901A5073033743 @default.
• W2012060901 hasAuthorship W2012060901A5085226848 @default.
• W2012060901 hasAuthorship W2012060901A5088078573 @default.
• W2012060901 hasConcept C104317684 @default.
• W2012060901 hasConcept C126322002 @default.
• W2012060901 hasConcept C134018914 @default.
• W2012060901 hasConcept C150194340 @default.
• W2012060901 hasConcept C170493617 @default.
• W2012060901 hasConcept C175805485 @default.
• W2012060901 hasConcept C185592680 @default.
• W2012060901 hasConcept C24998067 @default.
• W2012060901 hasConcept C2776683971 @default.
• W2012060901 hasConcept C2777203538 @default.
• W2012060901 hasConcept C2777911890 @default.
• W2012060901 hasConcept C2778324911 @default.
• W2012060901 hasConcept C2779276759 @default.
• W2012060901 hasConcept C2779670467 @default.
• W2012060901 hasConcept C2780536345 @default.
• W2012060901 hasConcept C526171541 @default.
• W2012060901 hasConcept C55493867 @default.
• W2012060901 hasConcept C62231903 @default.
• W2012060901 hasConcept C71315377 @default.
• W2012060901 hasConcept C71924100 @default.
• W2012060901 hasConcept C7876069 @default.
• W2012060901 hasConcept C80446465 @default.
• W2012060901 hasConcept C86803240 @default.
• W2012060901 hasConceptScore W2012060901C104317684 @default.
• W2012060901 hasConceptScore W2012060901C126322002 @default.
• W2012060901 hasConceptScore W2012060901C134018914 @default.
• W2012060901 hasConceptScore W2012060901C150194340 @default.
• W2012060901 hasConceptScore W2012060901C170493617 @default.
• W2012060901 hasConceptScore W2012060901C175805485 @default.
• W2012060901 hasConceptScore W2012060901C185592680 @default.
• W2012060901 hasConceptScore W2012060901C24998067 @default.
• W2012060901 hasConceptScore W2012060901C2776683971 @default.
• W2012060901 hasConceptScore W2012060901C2777203538 @default.
• W2012060901 hasConceptScore W2012060901C2777911890 @default.
• W2012060901 hasConceptScore W2012060901C2778324911 @default.
• W2012060901 hasConceptScore W2012060901C2779276759 @default.
• W2012060901 hasConceptScore W2012060901C2779670467 @default.
• W2012060901 hasConceptScore W2012060901C2780536345 @default.
• W2012060901 hasConceptScore W2012060901C526171541 @default.
• W2012060901 hasConceptScore W2012060901C55493867 @default.
• W2012060901 hasConceptScore W2012060901C62231903 @default.
• W2012060901 hasConceptScore W2012060901C71315377 @default.
• W2012060901 hasConceptScore W2012060901C71924100 @default.
• W2012060901 hasConceptScore W2012060901C7876069 @default.
• W2012060901 hasConceptScore W2012060901C80446465 @default.
• W2012060901 hasConceptScore W2012060901C86803240 @default.
• W2012060901 hasIssue "2" @default.
• W2012060901 hasLocation W20120609011 @default.
• W2012060901 hasLocation W20120609012 @default.
• W2012060901 hasOpenAccess W2012060901 @default.
• W2012060901 hasPrimaryLocation W20120609011 @default.
• W2012060901 hasRelatedWork W1981477956 @default.
• W2012060901 hasRelatedWork W1981538206 @default.
• W2012060901 hasRelatedWork W2012060901 @default.
• W2012060901 hasRelatedWork W2014046105 @default.
• W2012060901 hasRelatedWork W2019366294 @default.
• W2012060901 hasRelatedWork W2067289404 @default.
• W2012060901 hasRelatedWork W2071028118 @default.
• W2012060901 hasRelatedWork W2075052643 @default.
• W2012060901 hasRelatedWork W2143245501 @default.
• W2012060901 hasRelatedWork W3146137207 @default.
• W2012060901 hasVolume "148" @default.
• W2012060901 isParatext "false" @default.
• W2012060901 isRetracted "false" @default.
• W2012060901 magId "2012060901" @default.
• W2012060901 workType "article" @default.